Investigating the candidacy of the serotype specific rhamnan polysaccharide based glycoconjugates to prevent disease caused by the dental pathogen Streptococcus mutans

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1007/s10719-017-9798-z
AuthorSearch for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 
Name affiliation
  1. National Research Council Canada. Human Health Therapeutics
FormatText
TypeArticle
Journal titleGlycoconjugate Journal
ISSN0282-0080
1573-4986
Pages# of pages: 12
SubjectStreptococcus mutans; conjugate vaccine; serotype polysaccharide; rhamnan
Abstract
Publication date
PublisherSpringer
LanguageEnglish
Peer reviewedYes
NPARC number23002488
Export citationExport as RIS
Report a correctionReport a correction
Record identifierb98ce473-3e38-48e0-997b-cfd7c203c31e
Record created2017-11-16
Record modified2017-11-16
Date modified: